ArticleFrontiers in cardiovascular medicine2025
Beyond behaviors: do biological intermediates improve lifestyle scoring for blood pressure?
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension prevalence is high in Saudi Arabia. Both lifestyle behaviors and biological intermediates influence blood pressure (BP); however, there is limited evidence from the Middle East on whether composite lifestyle scores that integrate both domains would capture BP variation better than behavioral metrics alone. This study aimed to examine associations of an overall lifestyle risk score (behavioral + biological) and a behavioral-only score with BP outcomes. Methods: In a cross-sectional study of Saudi adults ( Results: Each 1-point higher BioBeh score was associated with lower SBP (-1.68 mmHg; 95% CI: -2.58, -0.79), lower DBP (-1.67 mmHg; 95% CI: -2.66, -0.68), and reduced odds of hypertension (OR 0.73; 95% CI: 0.63, 0.85), but not with elevated BP. No associations were found with the Beh score. Waist circumference was the strongest individual component [SBP -3.80 (-4.70, -2.91); DBP -3.31 (-4.30, -2.32) mmHg; hypertension OR 0.57; 95% CI: 0.49, 0.66]. Conclusions: In Saudi adults, a biologically enriched lifestyle score captures BP variation and hypertension risk more robustly than behavior-only metrics. These findings support risk stratification and prevention strategies that emphasize central adiposity alongside basic lipid and glucose profiles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.